Breast Lesion Localization Methods Market 2023-2028 Size, Demand, Forecast and Segmentation

According to IMARC Group’s latest report, titled “Breast Lesion Localization Methods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.’ the global breast lesion localization methods market size reached US$ 1,102.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,018.5 Million by 2028, exhibiting a growth rate (CAGR) of 10.1% during 2023-2028.

Breast lesion localization methods encompass numerous processes used to identify abnormal changes in breast tissue, called as breast lesions, resulting from disease or injury. Some generally utilized techniques comprise wire localization, carbon marking, radio-guided occult lesion localization (ROLL), radioactive seed localization (RSL), magnetic seed localization (Magseed), and intraoperative ultrasound (IOUS). These methods aid healthcare professionals and doctors in making informed choices and determining the most suitable treatment or surgery for the patient.

Breast Lesion Localization Methods Market Trends: 

The growing prevalence of breast cancer, on account of changing lifestyles and unhealthy diets of individuals, is primarily driving the breast lesion localization methods market. Furthermore, the escalating demand for this technique, owing to the increasing number of patients requiring lumpectomy and surgical biopsy procedures, ensuring precise removal of the target lesion is also augmenting the market growth. Apart from this, the launch of favorable initiatives to raise awareness about the advantages of early breast cancer detection is positively influencing the global market.

Moreover, the growing number of government and private reimbursement policies for biopsy and related medical procedures and the introduction of innovative breast lesion localization devices by leading companies are further bolstering the market growth. Besides this, the increasing investments in research and development (R&D) activities are acting as significant growth-inducing factors. Additionally, the growing number of individuals opting for cosmetic surgeries, such as breast enhancement, and improving medical infrastructure are also catalyzing the global market. In addition to this, several technological advancements and higher consumer healthcare spending are expected to drive the breast lesion localization methods market in the coming years.

Breast Lesion Localization Methods Market 2023-2028 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the global breast lesion localization methods market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Argon Medical Devices Inc.
  • Becton Dickinson and Company
  • Cook Group Incorporated
  • CP Medical Inc. (Theragenics Corporation)
  • Endomagnetics Ltd.
  • Hologic Inc.
  • IsoAid LLC
  • IZI Medical Products (Landauer Inc)
  • Laurane Medical LLC
  • Leica Biosystems Nussloch GmbH (Danaher Corporation)
  • Merit Medical Systems Inc
  • Sterylab S.r.l.

Key Market Segmentation:

The report has segmented the global breast lesion localization methods market on the basis of type, usage, end user and region

Breakup by Type:

  • Wire Localization
  • Radioisotope Localization
  • Magnetic Tracers Localization
  • Others

Breakup by Usage:

  • Tumor Identification
  • Sentinel Lymph Node Identification
    • Lumpectomy
    • Mastectomy

Breakup by End User:

  • Hospitals
  • Diagnostic Centres
  • Oncology Clinics
  • Ambulatory Surgical Centers

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Request a Free PDF Sample of the Report:

Key Highlights of the Report:                                                           

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:                                                                       

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US


134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800


Follow us on Twitter: @imarcglobal



Leave a Reply

Your email address will not be published.